Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 0.034% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CC(C)OCCCNC(=O)c1ccc2c(c1)ncn2C1CCCC1
b COc1cccc(N2CCN(C(=O)c3cccn4c(=O)c5c(C)c(C)sc5nc34)CC2)c1
Answer: a. CC(C)OCCCNC(=O)c1ccc2c(c1)ncn2C1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)OCCCNC(=O)c1ccc2c(c1)ncn2C1CCCC1
CC(C)OCCCNC(=O)c1ccc2c(c1)ncn2C1CCCC1
1-cyclopentyl-N-(3-propan-2-yloxypropyl)benzimidazole-5-carboxamide